Greenberg PE - Search Results

1

Management of anaemia: a critical and systematic review of the cost effectiveness of erythropoiesis-stimulating agents.

Duh MS, Weiner JR, White LA, Lefebvre P, Greenberg PE. Duh MS, et al. Among authors: greenberg pe. Pharmacoeconomics. 2008;26(2):99-120. doi: 10.2165/00019053-200826020-00002. Pharmacoeconomics. 2008. PMID: 18198931 Review.

2

Lower respiratory tract infections: impact on the workplace.

Birnbaum H, Morley M, Leong S, Greenberg P, Colice G. Birnbaum H, et al. Pharmacoeconomics. 2003;21(10):749-59. doi: 10.2165/00019053-200321100-00006. Pharmacoeconomics. 2003. PMID: 12828496

3

Economic implications of treatment-resistant depression among employees.

Greenberg P, Corey-Lisle PK, Birnbaum H, Marynchenko M, Claxton A. Greenberg P, et al. Pharmacoeconomics. 2004;22(6):363-73. doi: 10.2165/00019053-200422060-00003. Pharmacoeconomics. 2004. PMID: 15099122

4

The risks and costs of multiple-generic substitution of topiramate.

Duh MS, Paradis PE, Latrémouille-Viau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MF, LeLorier J. Duh MS, et al. Among authors: greenberg pe. Neurology. 2009 Jun 16;72(24):2122-9. doi: 10.1212/WNL.0b013e3181aa5300. Neurology. 2009. PMID: 19528520

5

Determinants of direct cost differences among US employees with major depressive disorders using antidepressants.

Birnbaum HG, Ben-Hamadi R, Greenberg PE, Hsieh M, Tang J, Reygrobellet C. Birnbaum HG, et al. Among authors: greenberg pe. Pharmacoeconomics. 2009;27(6):507-17. doi: 10.2165/00019053-200927060-00006. Pharmacoeconomics. 2009. PMID: 19640013

6

The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.

Duh MS, Cahill KE, Paradis PE, Cremieux PY, Greenberg PE. Duh MS, et al. Among authors: greenberg pe. Expert Opin Pharmacother. 2009 Oct;10(14):2317-28. doi: 10.1517/14656560903140525. Expert Opin Pharmacother. 2009. PMID: 19663636 Review.

7

Cost of depression: current assessment and future directions.

Greenberg PE, Birnbaum SA. Greenberg PE, et al. Expert Rev Pharmacoecon Outcomes Res. 2001 Oct;1(1):69-76. doi: 10.1586/14737167.1.1.69. Expert Rev Pharmacoecon Outcomes Res. 2001. PMID: 19807509

8

Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives.

Duh MS, Latypova A, Greenberg P. Duh MS, et al. Expert Rev Pharmacoecon Outcomes Res. 2006 Oct;6(5):577-90. doi: 10.1586/14737167.6.5.577. Expert Rev Pharmacoecon Outcomes Res. 2006. PMID: 20528504

9

Risk of hepatotoxicity-related hospitalizations among patients treated with opioid/acetaminophen combination prescription pain medications.

Duh MS, Vekeman F, Korves C, Lefebvre P, Dial E, Latremouille-Viau D, Wei RS, Stangle BE, Lafeuille MH, Michna E, Greenberg PE. Duh MS, et al. Among authors: greenberg pe. Pain Med. 2010 Nov;11(11):1718-25. doi: 10.1111/j.1526-4637.2010.00979.x. Pain Med. 2010. PMID: 21044262

10

Cost of illness: an ongoing battle worth fighting.

Greenberg PE. Greenberg PE. Pharmacoeconomics. 2014 Dec;32(12):1151-2. doi: 10.1007/s40273-014-0217-z. Pharmacoeconomics. 2014. PMID: 25204852 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters